Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers

Early diagnosis and dietary treatment do not prevent long-term complications, which mostly affect the central nervous system in classical galactosemia patients. The clinical outcome of patients is highly variable, and there is an urgent need for prognostic biomarkers. The aim of this study was first...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsink-Karssies, Mendy M, Ferdinandusse, Sacha, Geurtsen, Gert J, Hollak, Carla E M, Huidekoper, Hidde H, Janssen, Mirian C H, Langendonk, Janneke G, van der Lee, Johanna H, O’Flaherty, Roisin, Oostrom, Kim J, Roosendaal, Stefan D, Rubio-Gozalbo, M Estela, Saldova, Radka, Treacy, Eileen P, Vaz, Fred M, de Vries, Maaike C, Engelen, Marc, Bosch, Annet M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425409/
https://www.ncbi.nlm.nih.gov/pubmed/32954279
http://dx.doi.org/10.1093/braincomms/fcaa006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425409/
https://www.ncbi.nlm.nih.gov/pubmed/32954279
http://dx.doi.org/10.1093/braincomms/fcaa006

Ejemplares similares